HAIKOU CITY, China, Nov. 8 /Xinhua-PRNewswire/ -- China Pharma Holdings,
Inc. ("China Pharma") (OTC Bulletin Board: CPHI) today announced that the
Company will host a conference call at 10:00 am EST on Tuesday, November 14,
2006, to discuss results for the third quarter of 2006.
Joining Ms. Zhilin Li, President and CEO of China Pharma, will be Mr.
Xinhua Wu, Chief Financial Officer, and Mr. Donald Xu, Vice President,
Strategic Planning and Business Development. The Company plans to distribute
its earnings announcement earlier that same day.
To participate in the conference call, please dial the following number
five to ten minutes prior to the scheduled conference call time:
(888) 419-5570. International callers should dial (617) 896-9871. The
conference passcode is 66962583.
If you are unable to participate in the call at this time, a replay will
be available on Tuesday, November 14 at 12:00 am EST, through Tuesday,
November 21 at 12:00 am EST. To access the replay, dial (888) 286-8010.
International callers should dial (617) 801-6888. The conference passcode is
84660865.
This conference call will be broadcast live over the Internet and can be
accessed by all interested parties by clicking on
http://phx.corporate-ir.net/playerlink.zhtml?c=145098&s=wm&e=1414793. Please
access the link at least fifteen minutes prior to the start of the call to
register, download, and install any necessary audio software. For those unable
to participate during the live broadcast, a 90 day replay will be available
shortly after the call by accessing the same link.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic
and brand bio-pharmaceutical products in China that treat a wide range of
conditions, including infections, hepatitis, cardiovascular and CNS diseases,
and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson),
a specialty bio-pharmaceutical company headquartered in Haikou City, Hainan
province in China, is a wholly owned subsidiary of China Pharma Holdings.
Safe Harbor Statement Under the Private Securities Litigation Reform Act
of 1995: Any statements set forth above that are not historical facts are
forward-looking statements that involve risks and uncertainties that could
cause actual results to differ materially from those in the forward-looking
statements, which may include, but are not limited to, such factors as
unanticipated changes in product demand, increased competition, failure to
obtain or maintain intellectual property protection, downturns in the Chinese
economy, uncompetitive levels of research and development, failure to obtain
regulatory approvals, and other information detailed from time to time in the
Company's filings and future filings with the United States Securities and
Exchange Commission.